Kaynak: MarketBeat Haber Ajansı
1 ay önce•
Hisse Senedi Orta Önem
Novo Nordisk A/S Q2 Earnings Call Highlights

Novo Nordisk A/S Q2 Earnings Call Highlights

Novo Nordisk A/S NYSE: NVO reported second-quarter adjusted sales growth of 7% at constant exchange rates, supported by GLP-1 volume growth across its obesity and diabetes franchises, while lower realized prices and manufacturing-related costs weighed on margins.
İlgili Semboller 1
NVO NVO
Kaynak: MarketBeat
Kaynağı Ziyaret Et
0 0 0
Yorum Yap
Yorumlar
0
Henüz yorum yok
Bu habere ilk yorum yapan kişi olun.